The hemophilia treatment market, valued at approximately USD 14.84 billion in 2023, is experiencing a significant shift due to technological innovations, increased awareness, and a strong focus on improving patient outcomes. By 2032, the market is expected to grow at a 7.5% CAGR, reaching a valuation of USD 28.44 billion. Below is a detailed breakdown […]